4//SEC Filing
KOSKI ROBERT C 4
Accession 0001493152-23-000130
CIK 0001174940other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:20 PM ET
Size
7.3 KB
Accession
0001493152-23-000130
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI ROBERT C
Director10% Owner
Transactions
- Sale
Common Stock
2022-12-30$0.11/sh−42,357$4,469→ 1,102,295 total(indirect: See footnote) - Sale
Common Stock
2022-12-29$0.11/sh−36,648$3,885→ 176,191 total
Footnotes (3)
- [F1]The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]Shares owned directly by Robert C. Koski, a director of the Company.
- [F3]Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001234880
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:20 PM ET
- Size
- 7.3 KB